Akorn completes deal for Hi-Tech Pharmacal

SHARE Akorn completes deal for Hi-Tech Pharmacal

Akorn Inc. on Thursday completed its $640 million purchase of Hi-Tech Pharmacal Co. Inc.

Lake Forest-based Akorn makes generic and branded drugs, nasal sprays and ointments. Akorn expects the deal for Hi-Tech Pharmacal will diversify its product lines and make it more competitive to supply retail and institutional customers.

”We are excited to announce that we have completed the acquisition of Hi‐Tech, our largest acquisition

to date,” said Raj Rai, chief executive officer of Akorn. “This transformative acquisition diversifies our

revenue base and strengthens our capabilities in both manufacturing and R&D.”

Akorn has manufacturing facilities in downstate Decatur; Somerset, N.J.; Amityville, N.Y.; and Paonta Sahib, India.

Akorn to buy Hi-Tech Pharmacal for $640M

The Latest
Andrea Kersten, directora de COPA, expresó su “gran preocupación” por el comportamiento de los oficiales en una carta enviada la semana pasada al superintendente de la Policía de Chicago, Larry Snelling.
Former Trump Chief of Staff Mick Mulvaney and former Democratic California Representative Jackie Speier dive deep into the issues and politics of the 2024 showdown between President Joe Biden and former President Donald Trump on April 18.
Humberto Hernández llevaba a casa a Dontius Wilson, de 23 años, cuando recibieron disparos en el bloque 600 al oeste de la 69th St. Hernández se dio a la fuga. Wilson resultó herido y murió en el hospital.
En la última semana se detectaron tres casos, después que la ciudad registrara más de 50 en menos de un mes.
Also, we asked how excited you are to see the Bulls in the NBA’s play-in tournament. Let’s just say voters didn’t struggle to contain themselves.